1,2-dimethylhydrazine decreases expression ISO RGD:733022 6480464 1, 2-Dimethylhydrazine results in decreased expression of GZMB mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:733022 6480464 Dinitrochlorobenzene results in increased expression of GZMB mRNA CTD PMID:18652873 1-chloro-2,4-dinitrobenzene affects expression ISO RGD:733022 6480464 Dinitrochlorobenzene affects the expression of GZMB mRNA CTD PMID:22302311 1-chloro-2,4-dinitrobenzene increases expression EXP 6480464 Dinitrochlorobenzene results in increased expression of GZMB mRNA CTD PMID:21893156 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of GZMB mRNA, [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GZMB mRNA CTD PMID:26496021 , PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GZMB mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733022 6480464 Tetrachlorodibenzodioxin affects the expression of GZMB mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of GZMB mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1353495 6480464 Tetrachlorodibenzodioxin results in increased expression of GZMB mRNA CTD PMID:27783946 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733022 6480464 Tetrachlorodibenzodioxin results in increased expression of GZMB mRNA CTD PMID:26290441 2-tert-butylhydroquinone multiple interactions ISO RGD:733022 6480464 2-tert-butylhydroquinone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of GZMB protein] CTD PMID:30171972 3,7-dihydropurine-6-thione increases expression EXP 6480464 Mercaptopurine results in increased expression of GZMB mRNA CTD PMID:23358152 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of GZMB mRNA CTD PMID:20409345 4-(ethoxymethylene)-2-phenyloxazol-5-one decreases expression ISO RGD:733022 6480464 Oxazolone results in decreased expression of GZMB mRNA CTD PMID:11379042 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression EXP 6480464 Oxazolone results in increased expression of GZMB mRNA CTD PMID:21893156 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:733022 6480464 Oxazolone results in increased expression of GZMB mRNA CTD PMID:18652873 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of GZMB mRNA CTD PMID:21346803 5-azacytidine multiple interactions ISO RGD:1353495 6480464 Azacitidine inhibits the reaction [IL2 protein results in increased secretion of GZMB protein] CTD PMID:19394699 acetamide increases expression EXP 6480464 acetamide results in increased expression of GZMB mRNA CTD PMID:31881176 adenosine multiple interactions ISO RGD:733022 6480464 [Adenosine co-treated with Coformycin] results in decreased expression of GZMB mRNA CTD PMID:11992407 all-trans-retinoic acid decreases expression ISO RGD:1353495 6480464 Tretinoin results in decreased expression of GZMB protein CTD PMID:17107666 alpha-hexylcinnamaldehyde affects expression ISO RGD:733022 6480464 hexyl cinnamic aldehyde affects the expression of GZMB mRNA CTD PMID:22302311 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of GZMB mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:1353495 6480464 Antirheumatic Agents results in decreased expression of GZMB mRNA CTD PMID:24449571 Benzo[k]fluoranthene decreases expression ISO RGD:733022 6480464 benzo(k)fluoranthene results in decreased expression of GZMB mRNA CTD PMID:26377693 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of GZMB mRNA, [bisphenol A co-treated with Testosterone] results in increased expression of GZMB mRNA CTD PMID:26496021 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GZMB mRNA CTD PMID:31129395 bisphenol A increases expression ISO RGD:733022 6480464 bisphenol A results in increased expression of GZMB mRNA CTD PMID:26063408 bortezomib increases expression ISO RGD:1353495 6480464 Bortezomib results in increased expression of GZMB mRNA CTD PMID:20977926 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of GZMB mRNA CTD PMID:19167457 cadmium sulfate multiple interactions ISO RGD:733022 6480464 cadmium sulfate affects the reaction [MTF1 affects the expression of GZMB mRNA] CTD PMID:16221973 carbamazepine increases secretion ISO RGD:1353495 6480464 Carbamazepine results in increased secretion of GZMB protein CTD PMID:29644860 carbon nanotube decreases expression ISO RGD:733022 6480464 Nanotubes more ... CTD PMID:25554681 cholesterol multiple interactions ISO RGD:733022 6480464 [Cholesterol co-treated with 1, 2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of GZMB mRNA CTD PMID:22129739 chromium(6+) affects expression ISO RGD:733022 6480464 chromium hexavalent ion affects the expression of GZMB mRNA CTD PMID:28472532 coformycin multiple interactions ISO RGD:733022 6480464 [Adenosine co-treated with Coformycin] results in decreased expression of GZMB mRNA CTD PMID:11992407 copper atom multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in increased expression of GZMB mRNA CTD PMID:26033743 copper(0) multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in increased expression of GZMB mRNA CTD PMID:26033743 crocidolite asbestos decreases expression ISO RGD:733022 6480464 Asbestos, Crocidolite results in decreased expression of GZMB mRNA CTD PMID:29279043 cyclophosphamide increases expression ISO RGD:733022 6480464 Cyclophosphamide results in increased expression of GZMB mRNA CTD PMID:15331540 dichlorvos decreases expression ISO RGD:1353495 6480464 Dichlorvos results in decreased expression of GZMB protein CTD PMID:18063463 ethambutol increases secretion ISO RGD:1353495 6480464 Ethambutol results in increased secretion of GZMB protein CTD PMID:27933861 ethanol multiple interactions ISO RGD:733022 6480464 Ethanol inhibits the reaction [IL2 protein results in increased expression of GZMB mRNA] CTD PMID:12700414 folpet decreases expression ISO RGD:733022 6480464 folpet results in decreased expression of GZMB mRNA CTD PMID:31558096 fulvestrant decreases expression ISO RGD:1353495 6480464 fulvestrant results in decreased expression of GZMB mRNA, fulvestrant results in decreased expression of GZMB protein CTD PMID:20145137 fulvestrant increases expression ISO RGD:1353495 6480464 [fulvestrant results in increased expression of TGFB1 protein] which results in increased expression of GZMB mRNA CTD PMID:20145137 Fusarenone X increases expression ISO RGD:733022 6480464 fusarenon-X results in increased expression of GZMB mRNA CTD PMID:24983900 genistein increases expression ISO RGD:733022 6480464 Genistein results in increased expression of GZMB mRNA CTD PMID:32186404 heparin multiple interactions EXP 6480464 Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of GZMB mRNA] CTD PMID:16401727 imiquimod multiple interactions ISO RGD:733022 6480464 Imiquimod results in increased expression of and results in increased secretion of GZMB protein CTD PMID:31093508 ionomycin multiple interactions ISO RGD:733022 6480464 2-tert-butylhydroquinone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of GZMB protein], [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of GZMB protein CTD PMID:30171972 irinotecan affects expression EXP 6480464 Irinotecan affects the expression of GZMB mRNA CTD PMID:20097248 L-ascorbic acid decreases expression ISO RGD:733022 6480464 Ascorbic Acid deficiency results in decreased expression of GZMB mRNA CTD PMID:22306178 lipopolysaccharide multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of GZMB mRNA, Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of GZMB mRNA] CTD PMID:16401727 malathion decreases expression ISO RGD:733022 6480464 Malathion results in decreased expression of GZMB protein CTD PMID:32120800 malathion multiple interactions ISO RGD:733022 6480464 Plant Extracts inhibits the reaction [Malathion results in decreased expression of GZMB protein], Polyphenols inhibits the reaction [Malathion results in decreased expression of GZMB protein] CTD PMID:32120800 mercaptopurine increases expression EXP 6480464 Mercaptopurine results in increased expression of GZMB mRNA CTD PMID:23358152 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of GZMB mRNA, Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of GZMB mRNA] CTD PMID:16401727 nickel atom increases expression ISO RGD:1353495 6480464 Nickel results in increased expression of GZMB mRNA CTD PMID:25583101 nonanoic acid decreases expression ISO RGD:733022 6480464 pelargonic acid results in decreased expression of GZMB mRNA CTD PMID:11379042 nonanoic acid increases expression ISO RGD:733022 6480464 pelargonic acid results in increased expression of GZMB mRNA CTD PMID:18652873 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of GZMB mRNA CTD PMID:25729387 ozone decreases expression EXP 6480464 Ozone results in decreased expression of GZMB mRNA CTD PMID:26667333 ozone multiple interactions ISO RGD:733022 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of GZMB mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of GZMB mRNA CTD PMID:34911549 p-menthan-3-ol increases expression ISO RGD:1353495 6480464 Menthol results in increased expression of GZMB mRNA CTD PMID:26760959 paracetamol increases response to substance ISO RGD:733022 6480464 GZMB gene mutant form results in increased susceptibility to Acetaminophen CTD PMID:25168425 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of GZMB mRNA CTD PMID:32680482 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:733022 6480464 2-tert-butylhydroquinone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of GZMB protein], [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of GZMB protein CTD PMID:30171972 phthalaldehyde affects expression ISO RGD:733022 6480464 o-Phthalaldehyde affects the expression of GZMB mRNA CTD PMID:22302311 pirinixic acid decreases expression ISO RGD:733022 6480464 pirinixic acid results in decreased expression of GZMB mRNA CTD PMID:17426115 poly(I:C) multiple interactions ISO RGD:1353495 6480464 Particulate Matter inhibits the reaction [Poly I-C results in increased expression of GZMB mRNA] more ... CTD PMID:23618096 poly(I:C) increases expression ISO RGD:1353495 6480464 Poly I-C results in increased expression of GZMB mRNA, Poly I-C results in increased expression of GZMB protein CTD PMID:23618096 progesterone affects expression ISO RGD:733022 6480464 Progesterone affects the expression of GZMB mRNA CTD PMID:17251523 progesterone increases expression EXP 6480464 Progesterone results in increased expression of GZMB mRNA CTD PMID:21770760 purine-6-thiol increases expression EXP 6480464 Mercaptopurine results in increased expression of GZMB mRNA CTD PMID:23358152 pyrrolidine dithiocarbamate multiple interactions ISO RGD:733022 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [IL2 protein results in increased expression of GZMB mRNA] CTD PMID:12700414 quercetin increases expression ISO RGD:733022 6480464 Quercetin results in increased expression of GZMB mRNA CTD PMID:25862958 ranitidine multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of GZMB mRNA, Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of GZMB mRNA] CTD PMID:16401727 resveratrol decreases expression ISO RGD:733022 6480464 resveratrol results in decreased expression of GZMB mRNA CTD PMID:25280562 rifampicin increases secretion ISO RGD:1353495 6480464 Rifampin results in increased secretion of GZMB protein CTD PMID:27933861 silicon dioxide increases expression ISO RGD:733022 6480464 Silicon Dioxide results in increased expression of GZMB mRNA CTD PMID:29341224 sirolimus decreases expression ISO RGD:1353495 6480464 Sirolimus results in decreased expression of GZMB protein CTD PMID:16477233 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of GZMB mRNA CTD PMID:21297353 sodium arsenite decreases expression ISO RGD:733022 6480464 sodium arsenite results in decreased expression of GZMB protein CTD PMID:34166680 sodium arsenite multiple interactions ISO RGD:733022 6480464 Immune Checkpoint Inhibitors inhibits the reaction [sodium arsenite results in decreased expression of GZMB protein] CTD PMID:34166680 tamoxifen decreases expression ISO RGD:1353495 6480464 Tamoxifen results in decreased expression of GZMB mRNA, Tamoxifen results in decreased expression of GZMB protein CTD PMID:20145137 tamoxifen increases expression ISO RGD:1353495 6480464 [Tamoxifen results in increased expression of TGFB1 protein] which results in increased expression of GZMB mRNA CTD PMID:20145137 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of GZMB mRNA, [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GZMB mRNA CTD PMID:26496021 , PMID:32741896 toluene 2,4-diisocyanate decreases expression ISO RGD:733022 6480464 Toluene 2, 4-Diisocyanate results in decreased expression of GZMB mRNA CTD PMID:11379042 toluene 2,4-diisocyanate increases expression ISO RGD:733022 6480464 Toluene 2, 4-Diisocyanate results in increased expression of GZMB mRNA CTD PMID:18652873 topotecan increases expression EXP 6480464 Topotecan results in increased expression of GZMB mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of GZMB mRNA CTD PMID:25729387 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of GZMB mRNA CTD PMID:21893156 trimellitic anhydride affects expression ISO RGD:733022 6480464 trimellitic anhydride affects the expression of GZMB mRNA CTD PMID:22302311 trimellitic anhydride increases expression ISO RGD:733022 6480464 trimellitic anhydride results in increased expression of GZMB mRNA CTD PMID:19042947 valproic acid affects expression ISO RGD:733022 6480464 Valproic Acid affects the expression of GZMB mRNA CTD PMID:17292431 ziram decreases expression ISO RGD:1353495 6480464 Ziram results in decreased expression of GZMB protein CTD PMID:21859362 , PMID:22038140 zoledronic acid affects expression ISO RGD:1353495 6480464 zoledronic acid affects the expression of GZMB mRNA CTD PMID:19446661 zoledronic acid multiple interactions ISO RGD:1353495 6480464 IL2 protein affects the reaction [zoledronic acid affects the expression of GZMB mRNA] CTD PMID:19446661
